Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin® (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma
5/9/2013 11:37:13 AM
More...
|
Prometheus Laboratories Inc. Release: New Data Support Use of PROMETHEUS® Anser™ IFX Assay in Managing Infliximab Treatment Failure Among Inflammatory Bowel Disease Patients
10/22/2012 10:28:35 AM
More...
|
Prometheus Laboratories Inc. Launches New Monitoring Test to Help Guide Inflammatory Bowel Disease Management
8/1/2012 10:12:01 AM
More...
|
Clinipace Inc. Selected to Manage Prometheus Laboratories Inc. Oncology Program
7/17/2012 9:56:45 AM
More...
|
New Data Support Role of Prometheus Laboratories Inc.' Novel Assay in Optimizing IBD Treatment Management
5/23/2012 9:18:29 AM
More...
|
Supreme Court Throws Out Prometheus Laboratories Inc. Patent in Blood Test Dispute, Deals Blow to Biotechs
3/21/2012 7:40:24 AM
More...
|
Prometheus Laboratories Inc. Signs Research & Collaboration Agreement with Leading Worldwide Pharmaceutical Company
2/7/2012 11:02:00 AM
More...
|
Prometheus Laboratories Inc. Announces New Chief Commercial Officer
2/3/2012 8:58:58 AM
More...
|
Prometheus Laboratories Inc. Announces New Chief Medical Officer
11/14/2011 10:49:53 AM
More...
|
Prometheus Laboratories Inc. Launches Next Generation IBD Diagnostic Test
10/24/2011 12:00:34 PM
More...
|
|